CARTER BRUCE L A 4
4 · ENANTA PHARMACEUTICALS INC · Filed Mar 22, 2022
Insider Transaction Report
Form 4
CARTER BRUCE L A
Director
Transactions
- Exercise/Conversion
Common Stock
2022-03-21$25.58/sh+6,000$153,480→ 6,000 total - Sale
Common Stock
2022-03-21$66.70/sh−2,676$178,489→ 3,324 total - Sale
Common Stock
2022-03-21$67.23/sh−307$20,640→ 3,017 total - Sale
Common Stock
2022-03-21$68.66/sh−2,210$151,739→ 807 total - Sale
Common Stock
2022-03-21$69.52/sh−807$56,103→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-21−6,000→ 0 totalExercise: $25.58Exp: 2026-02-11→ Common Stock (6,000 underlying)
Footnotes (6)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in December 2021.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $66.28 to $66.99, inclusive.
- [F3]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $67.005 to $67.47, inclusive.
- [F4]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $68.509 to $68.76, inclusive.
- [F5]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $69.39 to $70.07, inclusive.
- [F6]100% of the shares subject to the option are fully vested and exercisable.